ONCOLINX

Oncolinx, in conjunction with the National Cancer Institute is developing the next generation of targeted cancer therapies: antibody-drug conjugates (ADCs). Oncolinx ADCs carry a patented, immune-activating drug payload called the Azonafide directly, and exclusively, to cancer cells, and not healthy cells, thereby avoiding many of the adverse side-effects of chemotherapy. The Oncolinx platform is partnered with more than 14 leading pharmaceutical companies and 6 academic labs all over the world— concurrently developing ADCs across 30 different cancer indications. Oncolinx aims to enter clinical trials with a partnered program in mid-2017.

#SimilarOrganizations #People #Financial #Website #More

ONCOLINX

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Medical

Founded:

2013-01-01

Address:

Boston, Massachusetts, United States

Country:

United States

Website Url:

http://www.oncolinx.com

Total Employee:

Status:

Active

Contact:

+44 2035141013

Email Addresses:

[email protected]

Total Funding:

1.06 M USD

Technology used in webpage:

Font Awesome Domain Not Resolving Apache AJAX Libraries API Wix Wix DNS

Similar Organizations

calimmune-logo

Current Employees Featured

sourav-sinha_image

Sourav Sinha
Sourav Sinha Co-founder, CEO @ Oncolinx
Co-founder, CEO
2014-01-01

allen-lin_image

Allen Lin
Allen Lin Co-Founder and CSO @ Oncolinx
Co-Founder and CSO

riley-ennis_image

Riley Ennis
Riley Ennis Co-Founder @ Oncolinx
Co-Founder
2014-10-01

Founder

allen-lin_image

Allen Lin

navin-nathan_image

Navin Nathan

riley-ennis_image

Riley Ennis

sourav-sinha_image

Sourav Sinha

Investors List

43-north_image

Official Site Inspections

http://www.oncolinx.com

Host Informations
Whois Informations

Loading ...